Logo image of LXRX

LEXICON PHARMACEUTICALS INC (LXRX) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:LXRX - US5288723027 - Common Stock

1.37 USD
+0.09 (+7.03%)
Last: 1/16/2026, 8:00:00 PM
1.35 USD
-0.02 (-1.46%)
After Hours: 1/16/2026, 8:00:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
LXRX revenue by date.LXRX revenue by date.
100K
-66.67%
1.204M
1,104.00%
31.081M
2,481.48%
48.677M
56.61%
17.588M
-63.87%
26.121M
48.52%
62.106M
137.76%
108.29M
74.36%
196.32M
81.29%
328.32M
67.24%
516.43M
57.29%
775.71M
50.21%
EBITDA
YoY % growth
LXRX ebitda by date.LXRX ebitda by date.
-100.4M
-15.67%
-171.196M
-70.51%
-196.583M
-14.83%
-62.482M
68.22%
-108.602M
-73.81%
-111.623M
-2.78%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
LXRX ebit by date.LXRX ebit by date.
-100.8M
-15.73%
-171.75M
-70.39%
-197.117M
-14.77%
-62.926M
68.08%
-106.332M
-68.98%
-110.511M
-3.93%
-119.804M
-8.41%
-28.437M
76.26%
74.665M
362.57%
210.94M
182.52%
397.44M
88.41%
652.86M
64.27%
Operating Margin
LXRX operating margin by date.LXRX operating margin by date.
-100,800.00%-14,264.95%-634.20%-129.27%-604.57%-423.07%-192.90%-26.26%38.03%64.25%76.96%84.16%
EPS
YoY % growth
LXRX eps by date.LXRX eps by date.
-0.61
0.00%
-0.80
-31.15%
-0.64
20.00%
-0.17
73.38%
-0.26
-55.45%
-0.23
12.75%
-0.14
39.65%
-0.08
41.48%
0.20
350.00%
0.57
180.00%
1.08
89.29%
1.47
35.85%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.07
21.80%
-0.07
5.29%
-0.07
-814.00%
-0.07
-78.50%
-0.09
-23.19%
Revenue
Q2Q % growth
3.204M
-87.93%
5.763M
356.66%
5.865M
-79.68%
7.395M
-47.86%
5.151M
60.77%
EBITDA
Q2Q % growth
-27.941M
13.23%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-28.408M
13.22%
-25.124M
2.16%
-26.098M
-798.55%
-26.677M
-118.89%
-32.186M
-13.30%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.04
77.78%
-0.070.0340.58%
Q2 2025
Q2Q % growth
0.01
105.88%
-0.080.09112.65%
Q1 2025
Q2Q % growth
-0.07
65.00%
-0.100.0329.61%
Q4 2024
Q2Q % growth
-0.09
55.00%
-0.130.0430.70%
Q3 2024
Q2Q % growth
-0.18
14.29%
-0.17-0.01-7.28%
Q2 2024
Q2Q % growth
-0.17
22.73%
-0.190.0211.66%
Q1 2024
Q2Q % growth
-0.20
-17.65%
-0.200.000.72%
Q4 2023
Q2Q % growth
-0.20
-25.00%
-0.220.029.75%
Q3 2023
Q2Q % growth
-0.21
-61.54%
-0.220.014.13%
Q2 2023
Q2Q % growth
-0.22
-37.50%
-0.18-0.04-23.43%
Q1 2023
Q2Q % growth
-0.17
-6.25%
-0.180.017.02%
Q4 2022
Q2Q % growth
-0.16
5.88%
-0.14-0.02-17.06%
Q3 2022
Q2Q % growth
-0.13
18.75%
-0.140.018.53%
Q2 2022
Q2Q % growth
-0.16
-23.08%
-0.160.000.30%
Q1 2022
Q2Q % growth
-0.16
-6.67%
-0.170.014.74%
Q4 2021
Q2Q % growth
-0.17
-325.00%
-0.190.028.76%
Q3 2021
Q2Q % growth
-0.16
-122.86%
-0.180.0211.38%
Q2 2021
Q2Q % growth
-0.13
79.37%
-0.160.0320.22%
Q1 2021
Q2Q % growth
-0.15
76.19%
-0.160.016.57%
Q4 2020
Q2Q % growth
-0.04 -0.280.2485.82%
Q3 2020
Q2Q % growth
0.70 0.270.43160.20%
Q2 2020
Q2Q % growth
-0.63 -0.62-0.01-1.63%
Q1 2020
Q2Q % growth
-0.63 -0.710.0811.08%
LXRX Yearly EPS VS EstimatesLXRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 1 -1
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
14.182M
710.40%
4.742M9.44M199.07%
Q2 2025
Q2Q % growth
28.866M
1,652.64%
4.965M23.901M481.39%
Q1 2025
Q2Q % growth
1.262M
11.68%
1.441M-179K-12.42%
Q4 2024
Q2Q % growth
26.554M
3,682.62%
6.61M19.944M301.72%
Q3 2024
Q2Q % growth
1.75M
980.25%
2.988M-1.238M-41.43%
Q2 2024
Q2Q % growth
1.647M
419.56%
2.887M-1.24M-42.95%
Q1 2024
Q2Q % growth
1.13M
4,608.33%
1.429M-299K-20.92%
Q4 2023
Q2Q % growth
702K 1.267M-565K-44.59%
Q3 2023
Q2Q % growth
162K 2.101M-1.939M-92.29%
Q2 2023
Q2Q % growth
317K 68.003K248.997K366.15%
Q1 2023
Q2Q % growth
24K 33.997K-9.997K-29.40%
Q4 2022
Q2Q % growth
51K-51K-100.00%
Q3 2022
Q2Q % growth
51K-51K-100.00%
Q2 2022
Q2Q % growth

-100.00%
51K-51K-100.00%
Q1 2022
Q2Q % growth
51K-51K-100.00%
Q4 2021
Q2Q % growth

-100.00%
%
Q3 2021
Q2Q % growth

-100.00%
%
Q2 2021
Q2Q % growth
200K
-97.83%
9.18K190.82K2,078.65%
Q1 2021
Q2Q % growth

-100.00%
1.71M-1.71M-100.00%
Q4 2020
Q2Q % growth
200K 112.2K87.8K78.25%
Q3 2020
Q2Q % growth
6.6M 17.21M-10.61M-61.65%
Q2 2020
Q2Q % growth
9.2M 9.006M194K2.15%
Q1 2020
Q2Q % growth
8M 7.944M56K0.70%
LXRX Yearly Revenue VS EstimatesLXRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -2.22% 1.04% 13.56%
Revenue0% -44.62% 0% -5.97%